As a one-dose solution, the Johnson & Johnson vaccine is a powerful tool for COVID-19 protection. The FDA’s pause of the vaccine will slow vaccination efforts for hard-to-reach populations and congregate settings. As an organization bringing the vaccine across the nation, Mobile Health CEO Andrew Shulman joins Good Day NBC to discuss the potential impacts.
TAKING SAFETY SERIOUSLY
“There is an advantage to the paused J&J COVID-19 vaccine,” Mobile Health CEO Andrew Shulman. “An exceedingly rare (vaccine) issue was caught. That means the system is working. I hope people will see vaccines are safe and effective and we can surmount some vaccine hesitancy.” Shulman hopes agencies will resume shipment so it can be administered in hard-to-reach places like homeless shelters and rural areas. “It can be challenging to get those patients back for their necessary second dose,” he said.
REBUILDING CONFIDENCE
How can employers rebuild confidence within their walls? With wavering vaccination rates and the unpredictable climate, showing that you are also taking safety seriously can make a real impact. Consistent COVID-19 testing can be the peace of mind your employees need to focus on their job.
Mobile health has been disease testing for 38 years – our on-site COVID-19 testing programs are proven and perfected. We start with understanding your patients and locations, then create a comprehensive operational plan. From patient arrival to result notification, Mobile Health handles all the details for a successful event. Talk to an expert today.
